CALCA and migraine disorder: Targeting calcitonin gene-related peptide (CGRP) and its receptor has opened a new era in the therapy of migraine, but it is still an undertreated disease, despite its high prevalence, serious physical and mental problems for affected individuals, and high burden for societies.